CoChat

Follow-up intervals in patients with Cushing’s disease: recommendations from a panel of experienced pituitary clinicians

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Purpose Follow-up guidelines are needed to assess quality of care and to ensure best long-term outcomes for patients with Cushing's disease (CD). The purpose of this study was to assess agreement by experts on recommended follow-up intervals for CD patients at different phases in their treatment course. Methods The RAND/UCLA modified Delphi process was used to assess expert consensus. Eleven clinicians who regularly manage CD patients rated 79 hypothetical patient scenarios before and after ("second round") an in-person panel discussion to clarify definitions. Scenarios described CD patients at various time points after treatment. For each scenario, panelists recommended follow-up intervals in weeks. Panel consensus was assigned as follows: "agreement" if no more than two responses were outside a 2 week window around the median response; "disagreement" if more than two responses were outside a 2 week window around the median response. Recommendations were developed based on second round results. Results Panel agreement was 65.9% before and 88.6% after the in-person discussion. The panel recommended follow-up within 8 weeks for patients in remission on glucocorticoid replacement and within 1 year of surgery; within 4 weeks for patients with uncontrolled persistent or recurrent disease; within 8-24 weeks in post-radiotherapy patients controlled on medical therapy; and within 24 weeks in asymptomatic patients with stable plasma ACTH concentrations after bilateral adrenalectomy.…

Overview

Integrity signals

Registry

Crossref · 10.1007/s11102-017-0801-2

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 29 references

Cited by

See all 11

Metadata

Authors
Geer, E. B., Ayala, A., Bonert, V., Carmichael, J. D., Gordon, M. B., Katznelson, L., Manuylova, E., Shafiq, I., Surampudi, V., Swerdloff, R. S., Broder, M. S., Cherepanov, D., Eagan, M., Lee, J., Said, Q., Neary, M. P., & Biller, B. M. K.
Affiliations
  • Memorial Sloan Kettering Cancer Center (US)
  • University of Miami (US)
  • Cedars-Sinai Medical Center (US)
  • University of Southern California (US)
  • Allegheny General Hospital (US)
  • Stanford Medicine (US)
  • University of Rochester Medicine (US)
  • Harbor–UCLA Medical Center (US)
  • Partnership for Health Analytic Research (US)
  • Massachusetts General Hospital (US)
Corresponding author
Geer, Eliza B.
Venue
Pituitary
Published
2017-03-09
Volume
20
Issue
4
Pages
422-429
ISSN
  • 1386-341X (ISSN-L)
  • 1573-7403
OpenAlex
W2594670971
Cited by
11
References
29
Citations by year
2026: 2 · 2024: 3 · 2022: 1 · 2021: 2 · 2020: 3
FWCI
0.65
Type
journal article
Language
en
Open access
closed
Locations
  • Pituitary (publishedVersion)
  • PubMed (publishedVersion)
Funders
Novartis Pharmaceuticals Corporation
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
Cushing's disease, follow-up interval, post-treatment monitoring, expert consensus, pituitary surgery, adrenalectomy, radiotherapy, glucocorticoid replacement therapy, ACTH, quality of care
MeSH terms
Adrenalectomy, Adrenocorticotropic Hormone, Glucocorticoids, Humans, Pituitary Gland, Pituitary ACTH Hypersecretion

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Follow-up intervals in patients with Cushing’s disease: recommendations from a panel of experienced pituitary clinicians. https://app.cochat.ai/papers/10.1007/s11102-017-0801-2
The paper
Geer, E. B., Ayala, A., Bonert, V., Carmichael, J. D., Gordon, M. B., Katznelson, L., Manuylova, E., Shafiq, I., Surampudi, V., Swerdloff, R. S., Broder, M. S., Cherepanov, D., Eagan, M., Lee, J., Said, Q., Neary, M. P., & Biller, B. M. K. (2017). Follow-up intervals in patients with Cushing’s disease: recommendations from a panel of experienced pituitary clinicians. Pituitary. https://doi.org/10.1007/s11102-017-0801-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.